RESUMO
Microsporidiosis is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiency. Fumagillin is an effective treatment against Enterocytozoon bieneusi, one of the two main species causing the microsporidiosis involved in human diseases. We report the first case, to our knowledge, of a probable drug-induced aseptic meningoencephalitis, after administration of fumagillin in a kidney transplant recipient with microsporidiosis.
Assuntos
Antifúngicos/efeitos adversos , Cicloexanos/efeitos adversos , Ácidos Graxos Insaturados/efeitos adversos , Transplante de Rim/efeitos adversos , Meningoencefalite/etiologia , Microsporidiose/tratamento farmacológico , Cicloexanos/uso terapêutico , Ácidos Graxos Insaturados/uso terapêutico , Feminino , Humanos , Hospedeiro Imunocomprometido , Pessoa de Meia-Idade , Sesquiterpenos/efeitos adversos , Sesquiterpenos/uso terapêuticoRESUMO
Eight cases of diarrhoea, including two cases of haemolytic uraemic syndrome (HUS), were identified among 22 French tourists who travelled to Turkey in September 2011. A strain of Escherichia coli O104:H4 stx2-positive, eae-negative, hlyA-negative, aggR-positive, ESBL-negative was isolated from one HUS case. Molecular analyses show this strain to be genetically similar but not indistinguishable from the E. coli O104:H4 2011 outbreak strain of France and Germany. Although the source of infection was not identified, we conclude that the HUS cases had probably been infected in Turkey.